Showing results (491-500 of 505) with videos related to
Sort By:
Pageof 51
British Journal of Cancer|April 1, 1996
Childhood leukaemia in Europe after Chernobyl: 5 year follow-upD M Parkin, D Clayton, R J Black, et al.Canada Communicable Disease Report = Releve Des Maladies Transmissibles Au Canada|July 10, 2019
Quebec's Multi-Party Observatory on Zoonoses and Adaptation to Climate ChangeG Germain, A Simon, J Arsenault, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 30, 2016
Clinical characteristics and prognostic factors of plasmablastic lymphoma patients: analysis of 135 patients from the LYSA groupE Tchernonog, P Faurie, P Coppo, et al.Annals of Hematology|September 2, 2016
Circulating Cd34+ cell count differentiates primary myelofibrosis from other Philadelphia-negative myeloproliferative neoplasms: a pragmatic studyC Orvain, D Luque Paz, I Dobo, et al.Leukemia|March 1, 1996
A prospective randomized trial of idarubicin vs daunorubicin in combination chemotherapy for acute myelogenous leukemia of the age group 55 to 75J Reiffers, F Huguet, A M Stoppa, et al.Journal of Neurochemistry|April 11, 2007
Evaluating the suitability of nicotinic acetylcholine receptor antibodies for standard immunodetection proceduresN Moser, N Mechawar, I Jones, et al.Nature Medicine|April 15, 1999
Stable restoration of the sarcoglycan complex in dystrophic muscle perfused with histamine and a recombinant adeno-associated viral vectorJ P Greelish, L T Su, E B Lankford, et al.Revue Des Maladies Respiratoires|May 24, 2007
[IFCT-0302 trial: randomised study comparing two follow-up schedules in completely resected non-small cell lung cancer]V Westeel, M P Lebitasy, M Mercier, et al.ESMO Open|May 27, 2023
Efficacy of immunotherapy in mismatch repair-deficient advanced colorectal cancer in routine clinical practice. An AGEO studyE Alouani, M Mercier, C Flecchia, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 16, 2017
Reduced-intensity versus reduced-toxicity myeloablative fludarabine/busulfan-based conditioning regimens for allografted non-Hodgkin lymphoma adult patients: a retrospective study on behalf of the Société Francophone de Greffe de Moelle et de Thérapie CellulaireA Le Bourgeois, M Labopin, D Blaise, et al.Pageof 51